Human albumin impairs amyloid β-peptide fibrillation through its C-terminus: From docking Modeling to protection against neurotoxicity in Alzheimer's disease
-
Add time:07/16/2019 Source:sciencedirect.com
Alzheimer's disease (AD) is a neurodegenerative process characterized by the accumulation of extracellular deposits of amyloid β-peptide (Aβ), which induces neuronal death. Monomeric Aβ is not toxic but tends to aggregate into β-sheets that are neurotoxic. Therefore to prevent or delay AD onset and progression one of the main therapeutic approaches would be to impair Aβ assembly into oligomers and fibrils and to promote disaggregation of the preformed aggregate. Albumin is the most abundant protein in the cerebrospinal fluid and it was reported to bind Aβ impeding its aggregation. In a previous work we identified a 35-residue sequence of clusterin, a well-known protein that binds Aβ, that is highly similar to the C-terminus (CTerm) of albumin. In this work, the docking experiments show that the average binding free energy of the CTerm-Aβ1–42 simulations was significantly lower than that of the clusterin-Aβ1–42 binding, highlighting the possibility that the CTerm retains albumin's binding properties. To validate this observation, we performed in vitro structural analysis of soluble and aggregated 1 μM Aβ1–42 incubated with 5 μM CTerm, equimolar to the albumin concentration in the CSF. Reversed-phase chromatography and electron microscopy analysis demonstrated a reduction of Aβ1–42 aggregates when the CTerm was present. Furthermore, we treated a human neuroblastoma cell line with soluble and aggregated Aβ1–42 incubated with CTerm obtaining a significant protection against Aβ-induced neurotoxicity. These in silico and in vitro data suggest that the albumin CTerm is able to impair Aβ aggregation and to promote disassemble of Aβ aggregates protecting neurons.
We also recommend Trading Suppliers and Manufacturers of C-PEPTIDE (1-35) (HUMAN) (cas 11097-48-6). Pls Click Website Link as below: cas 11097-48-6 suppliers
Prev:A two-generation chronic mixture toxicity study of clophen A60 (cas 11096-99-4) and diethyl phthalate on histology of adrenal cortex and thyroid of rats
Next:Association of C-peptide with diabetic vascular complications in type 2 diabetes) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Is C-peptide a predictor of severity of coronary artery disease in metabolic syndrome? An observational study07/25/2019
- Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control07/24/2019
- A sensitive electrochemiluminescent biosensor based on AuNP-functionalized ITO for a label-free immunoassay of C-peptide07/23/2019
- C-terminal degradation of PYY peptides in plasma abolishes effects on satiety and beta-cell function07/22/2019
- LIPID DOMAINS IN LB FILMS AND GIANT VESICLES TO STUDY GBV-C PEPTIDES INTERACTION IN THE CONTEXT OF HIV-1 FP INHIBITION AT MEMBRANES07/20/2019
- Neuroprotective effects of 1`δ-1`-acetoxyeugenol acetate on Aβ(25-35) induced cognitive dysfunction in mice07/21/2019
- C-type natriuretic peptide signaling in human follicular environment and its relation with oocyte maturation07/19/2019
- Development of a double-antibody sandwich ELISA for rapid detection to C-peptide in human urine07/18/2019
- Association of C-peptide with diabetic vascular complications in type 2 diabetes07/17/2019


